loader image
Saturday, October 4, 2025
92.3 F
McAllen
- Advertisement -

Governor Signs Ibogaine Treatment Research into Law

Translate to Spanish or other 102 languages!

Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. Photo: Office of The Governor
Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. Photo: Office of The Governor
- Advertisement -

AUSTIN — Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. 

“Texas is home to more veterans than any other state,” said Governor Abbott. “Many of those veterans suffer from injuries both seen and unseen. A therapy that has shown great promise in treating those conditions is ibogaine. This law authorizes a Food and Drug Administration approved clinical drug trial that will seek approval of ibogaine as a medication for the treatment of opioid use disorder and other behavioral health conditions, especially those suffered by our veterans. Texas will now lead the way in America for the evaluation of ibogaine as a potential medication that can help improve the lives of so many veterans.” 

View the Governor’s full bill signing ceremony here.

- Advertisement -

The Governor was joined at the bill signing ceremony by Speaker Dustin Burrows, Senator Tan Parker, Senator Charles Perry, and dozens of Texas supporters.

Ibogaine is a plant-based, psychoactive substance that can help treat opioid use disorder, depression, and post-traumatic stress disorder. Senate Bill 2308 allows the Texas Health and Human Services Commission to provide state matching funds for a Food and Drug Administration drug trial managed by a public university in partnership with a drug company and hospital.

Senate Bill 2308 (Parker/Harris) authorizes clinical drug trials on ibogaine to research the potential for treatment of opioid use disorder, depression, and post-traumatic stress disorder.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Ignoring cholesterol until middle age is a bad idea

Unhealthy cholesterol levels are a major risk factor for heart disease and stroke. Bowers, now a nursing professor at Purdue University Northwest in Hammond, Indiana, has attempted to address the issue. But she agreed cholesterol management is not something young adults usually worry about.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

STHS Children’s to Host Monster Jam Patient Meet & Greet, Oct. 9th

On Thursday, October 9, 2025, from 2:00 – 4:00 p.m., the pediatric patients at South Texas Health System Children’s will have the opportunity to experience monster truck magic without leaving the hospital grounds.

Daily combo of water, coffee, and tea linked to longevity

water does not only have to come from the ubiquitous water bottle — other drinks and food can provide a good proportion of your daily needs.
- Advertisement -
×